Oaktree Acquisition Corp. III Life Sciences
OACCNasdaqFinancials · Blank Checks · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | |
|---|---|---|
| Revenue | — | — |
| Operating income | −$1.2M | −$351,806 |
| Net income | $7.3M | $1.3M |
| Total assets | $203.1M | $195.3M |
| Total liabilities | $8.3M | $7.7M |
| Equity | −$6.8M | $0 |
| EPS (diluted) | — | — |
| Shares out. | — | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −107.7%
- Return on assets
- 3.6%
- Return on capital (ROCE)
- −0.6%
- Liabilities / assets
- 4.1%
- Debt / equity
- —
- Book value / share
- —
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- 447.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -0.99distress
- Accruals / assets
- 3.8%clean
- Piotroski F-Score
- 2/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Fort Baker Capital Management LpPassive (13G)May 15, 2026
- Goldman Sachs Group IncPassive (13G)May 11, 2026
- Barclays PlcPassive (13G)Feb 11, 2026
- Millennium Management LlcPassive (13G)Jul 15, 2025
- Aqr Capital Management LlcPassive (13G)May 14, 2025
- Healthcare Of Ontario Pension Plan Trust FundPassive (13G)May 14, 2025
- Oaktree Acquisition Holdings Iii Ls, LlcPassive (13G)Feb 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Oaktree Acquisition Holdings Iii Ls, Llc10% owner | Oct 30, 2024 | Conversion | 33,981 | $10.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 26,870 | 42.3 | -0.1% |
| Apr 30, 2026 | 26,885 | 40.4 | -0.8% |
| Apr 15, 2026 | 27,093 | 1.0 | -45.5% |
| Mar 31, 2026 | 49,748 | 2.3 | -0.9% |
| Mar 13, 2026 | 50,189 | 1.0 | -0.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeOct 29, 2025
- Director / officer changeOct 17, 2025
- Director / officer changeJun 6, 2025
- Director / officer changeJan 7, 2025
- Other material eventDec 11, 2024
- Unregistered equity sale · Other material eventNov 5, 2024
- Other material eventOct 31, 2024
- Entered a material agreement · Unregistered equity sale · Amended charter or bylaws · Other material eventOct 25, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13GMay 15, 2026
- 10-QMay 13, 2026
- SCHEDULE 13GMay 11, 2026
- 10-KMar 26, 2026
- SCHEDULE 13G/AFeb 11, 2026
- 10-QNov 13, 2025
- 3Oct 29, 2025
- 8-KOct 29, 2025
- 3Oct 22, 2025
- 8-KOct 17, 2025
- SCHEDULE 13G/AAug 12, 2025
- 10-QAug 12, 2025
- SCHEDULE 13G/AJul 15, 2025
- 3Jun 16, 2025
- 8-KJun 6, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.